Prescription Drug Monitoring Program
RULE NO:RULE TITLE:
64K-1.005Privacy of Information
SECOND NOTICE OF CHANGE
Notice is hereby given that the following changes have been made to the proposed rule in accordance with subparagraph 120.54(3)(d)1., F.S., published in Vol. 41 No. 187, September 25, 2015 issue of the Florida Administrative Register. The Joint Administrative Procedures Committee, in a letter dated December 9, 2015, indicated that the Notice of Change published in Vol. 41 No. 236, December 8, 2015, issue of the Florida Administrative Register incorrectly stated the publication information of the proposed rule as Vol. 41, No. 156, August 12, 2015. The correct publication date is stated above. The Notice of Change also failed to make a necessary substantive change to subsection (8) of the rule and include a law implemented as follows:
64K-1.005 Privacy of Controlled Substance Prescription Dispensing Information.
(1) through (7) No change.
(8) Agency administrators shall provide a quarterly report to the pProgram manager with the status of each active investigation case which has required program database access. The report shall include, at a minimum, whether the case is active or inactive and the disposition, if applicable.
Rulemaking Authority 893.055 FS. Law Implemented 893.055, 893.0551 FS. History–New 11-24-11, Amended .
THE PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE IS: Rebecca Poston, Program Manager, Prescription Drug Monitoring Program, 4052 Bald Cypress Way, Bin #C-16, Tallahassee, Florida 32399 or Rebecca.Poston@FlHealth.gov.
